Year 2019 / Volume 111 / Number 5
Case Report
Leukocytoclastic vasculitis after vaccination in a patient with inflammatory bowel disease

402-404

DOI: 10.17235/reed.2019.5963/2018

María Fernández Prada, Paula Alonso Penanes, Patricia Morales del Burgo, Isabel Pérez Martinez, María Clara Villa del Amo,

Abstract
Patients with inflammatory bowel disease are likely to receive immunomodulation treatment and therefore, should be properly vaccinated. Despite their proven safety, vaccines are not exempt from adverse reactions. The clinical case was a young female with ulcerative colitis under mesalazine treatment, who developed leukocytoclastic vasculitis following vaccination for pneumococci, varicella and hepatitis A. This adverse reaction after the previously mentioned vaccines is barely described in the literature and has never been reported in a patient with an underlying condition.
Share Button
New comment
Comments
No comments for this article
References
1. Dulai PS, Singh S, Casteele NV, Boland B, Sandborn W. How will evolving future therapies and strategies change how we position the use of biologics in moderate to severely active inflammatory bowel disease. Inflamm Bowel Dis. 2016;22:998–1009. doi: 10.1097/MIB.0000000000000661.
2. Kantsø B, Halkjær SI, Thomsen OØ, Belard E, Gottschalck IB, Jørgensen CS, et al. Immunosuppressive drugs impairs antibody response of thepolysaccharide and conjugated pneumococcal vaccines in patients with Crohn’s disease. Vaccine. 2015;33:5464-9. doi: 10.1016/j.vaccine.2015.08.011.
3. Rey Jurado E, Tapia F, Muñoz Durango N, Lay MK, Carreño LJ, Riedel AC, et al. Assessing the importance of domestic vaccine manufacturing centers: an overview of immunization programs, vaccine manufacture, and distribution. Front Inmunol. 2018;9:26. doi: 10.3389/fimmu.2018.00026
4. Jovani Casano V, Fernández Carballido C, Íbero Díaz I. Vasculitis leucocitoclásticas. En: Sociedad Valenciana de Reumatología. Enfermedades Reumáticas. Actualización SVR. [Libro en Internet]. Valencia: Ibañez y Plaza; 2013 [acceso 10 de agosto de 2018]. p. 367-381. Disponible en: http://www.svreumatologia.com/wp-content/uploads/2015/06/Actualizacion-Enfermedades-Reumaticas-Actualizacion-SVR-II-Edicion.pdf
5. Lodhia N. The Appropriate Use of Vaccines in Patients With Inflammatory Bowel Disease. J Clin Gastroenterol 2014;48:395-401. doi: 10.1097/MCG.0000000000000086
6. Felicetti P, Trotta F, Bonetto C, et al. Spontaneous reports of vasculitis as an adverse event following immunization: A descriptive analysis across three international databases. Vaccine 2016;34:6634-40. doi: 10.1016/j.vaccine.2015.09.027.
7. Bonetto C, Trotta F, Felicetti P, et al. Vasculitis as an adverse event following immunization - Systematic literature review. Vaccine. 2016;34(51):6641-51. doi: 10.1016/j.vaccine.2015.09.026.
8. Jariwala S, Vernon N, Shliozberg J. Henoch-Schönlein purpura after hepatitis A vaccination. Ann Allergy Asthma Immunol. 2011;107:180-1. doi: 10.1016/j.anai.2011.05.006.
9. Gerecitano J, Friedman-Kien A, Chazen GD. Allergic reaction to varicella vaccine. Ann Intern Med. 1997;126:833-4. PMID: 9148672.
10. Fox BC, Peterson A. Leukocytoclastic vasculitis after pneumococcal vaccination. Am J Infect Control. 1998;26:365-6. PMID: 9638297.
Related articles

Letter

Broadening perspectives in the treatment of chronic pouchitis

DOI: 10.17235/reed.2024.10865/2024

Letter

Tofacitinib-induced eosinophilia

DOI: 10.17235/reed.2023.9831/2023

Letter

Perianal Paget’s disease

DOI: 10.17235/reed.2022.9304/2022

Letter

Chinese dragon sign of ulcerative colitis

DOI: 10.17235/reed.2022.9154/2022

Letter

Ulcerative colitis exacerbated by strongyloidiasis

DOI: 10.17235/reed.2022.9044/2022

Review

Clinical settings with tofacitinib in ulcerative colitis

DOI: 10.17235/reed.2022.8660/2022

Letter

Mesalazine induced interstitial pneumonitis in the COVID era

DOI: 10.17235/reed.2022.8635/2021

Letter

The effect of Adacolumn® on ulcerative colitis with COVID-19

DOI: 10.17235/reed.2020.7156/2020

Letter

Sweet syndrome in severe ulcerative flare

DOI: 10.17235/reed.2020.6995/2020

Digestive Diseases Image

Gastrointestinal and renal involvement in systemic vasculitis

DOI: 10.17235/reed.2020.6965/2020

Letter to the Editor

Ulcerative colitis with gastric and duodenal involvement

DOI: 10.17235/reed.2017.4685/2016

Editorial

Specialist care in the management of inflammatory bowel disease

DOI: 10.17235/reed.2016.4628/2016

Original

Mercaptopurine and inflammatory bowel disease: the other thiopurine

DOI: 10.17235/reed.2016.4546/2016

Case Report

Mesalamine-induced myopericarditis - A case report

DOI: 10.17235/reed.2016.4016/2015

Citation tools
Fernández Prada M, Alonso Penanes P, Morales del Burgo P, Pérez Martinez I, Villa del Amo M. Leukocytoclastic vasculitis after vaccination in a patient with inflammatory bowel disease. 5963/2018


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 1207 visits.
This article has been downloaded 246 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 08/10/2018

Accepted: 18/12/2018

Online First: 12/03/2019

Published: 07/05/2019

Article revision time: 53 days

Article Online First time: 155 days

Article editing time: 211 days


Share
This article hasn't been rated yet.
Reader rating:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2024 y Creative Commons. The Spanish Journal of Gastroenterology